Interlaminar Device Market Trends

  • Report ID: 3974
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Interlaminar Device Market Trends

Growth Drivers

  • Upsurge in Diabetes Mellitus Cases- Numerous spine conditions, such as spinal stenosis, spondylolisthesis, and disc herniation, can be brought on by diabetes. These conditions can make it difficult to walk or stand for extended periods because they can induce discomfort in the spine, numbness, and weakness in the legs and back. People with diabetes may experience excessively high blood sugar levels. This can harm blood vessels and nerves all over the body, including the blood vessels and nerves in the spine. Spinal problems may result from injury to these nerves and blood vessels.                  
  • Growing Cases of Sports Injuries – Chronic back pain can be caused by sports injuries which may be treated by interlaminar devices. Therefore, with a surge in the incidence of sports injuries, the market demand is also expected to increase.  Approximately 9% of all new cases of spinal cord injuries in the United States are related to sports activities.
  • The Presence of Large Medical Equipment Manufacturers-The improvement of the medical facilities and the implementation of innovative health-related initiatives by manufacturers are factors also expected to spur the market expansion. In Poland, for instance, between 2004 and 2020, nearly 14,000 projects related to healthcare were executed.

Challenges

  • Unavailability of Proper Healthcare Infrastructure in Underdeveloped Nations - The lack of proper medical facilities is one of the major factors predicted to slow down the market growth. For instance, the unavailability can result in a lack of awareness about interlaminar devices which can lead to delayed treatment in underdeveloped regions.
  • Availability of Alternate Treatments
  • Lack of Skilled Professionals

Global Interlaminar Device Market: Key Insights

Healthcare Expenditure per Capita, (USD), 2015-2018

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Base Year

2024

Forecast Year

2025-2037

CAGR

6.2%

Base Year Market Size (2024)

USD 629.19 million

Forecast Year Market Size (2037)

USD 1.37 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3974
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of interlaminar device is estimated at USD 693.15 million.

The interlaminar device market size was valued at USD 629.19 million in 2024 and is likely to cross USD 1.37 billion by 2037, expanding at more than 6.2% CAGR during the forecast period i.e., between 2025-2037. Growing Cases of Sports Injuries and the growing advancements in spine surgery technologies across the globe will boost the market growth.

North America industry is anticipated to account for largest revenue share of 38% by 2037, impelled by rising adoption of interlaminar devices in the region.

The major players in the market are NuVasive, Inc., Zimmer Biomet, Life Spine, Inc., Xtant Medical, Alphatec Holdings, Inc., Amedica Corporation, Paradigm Health System, Bioventus LLC, Medical Device Business Services, Inc., Meditech Spine, LLC
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample